Toggle navigation
Home
Search
Services
Blog
Contact
About
Production of A Recombinant H5 N1 Vaccine for Phase 1
Smith, Gail
Protein Sciences Corporation, Meriden, CT, United States
Search 21 grants from Gail Smith
Search grants from Protein Sciences Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
High Throughput Screen to Discover Modulators of TREM2 Activity
Elucidating the Effect of Disc 1 on Neurodevelopment and Synaptic Transmission
Progression of Uveitis and CD8 uveitogenic T cells
Support Services for CCD/UFE Panel Meeting and Initial Related Processing
Rethinking Courses of Study: National Faculty Networks
Recently added grants:
Long-Term Islet Function and Impact after Total Pancreatectomy with Islet Autotransplant (LIFT)
Identifying low dose measurement error corrected effects of multiple pollutants using causal modeling
A novel cholinergic circuitry in alcoholic liver disease (NIAAA)
Structure-guided and high-throughput engineering of genetically encoded sensors for reactive oxygen species
Exploiting the VISTA Pathway to Prevent Acute GVHD and Control Steroid Refractory Disease
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AI085333-002
Application #
2830748
Study Section
Project Start
1997-12-19
Project End
1998-12-18
Budget Start
1998-06-16
Budget End
1998-04-18
Support Year
Fiscal Year
1998
Total Cost
Indirect Cost
Institution
Name
Protein Sciences Corporation
Department
Type
DUNS #
City
Meriden
State
CT
Country
United States
Zip Code
06450
Related projects
NIH 1998
N01 AI
Production of A Recombinant H5 N1 Vaccine for Phase 1
Smith, Gail / Protein Sciences Corporation
NIH 1998
N01 AI
Production of A Recombinant H5 N1 Vaccine for Phase 1
Smith, Gail / Protein Sciences Corporation
Comments
Be the first to comment on this grant